Skip to main content
Clinical Trials/NCT06201195
NCT06201195
Completed
Not Applicable

Contribution of Anterior Femoral Cutaneous Nerve Block to Postoperative Analgesia for Total Knee Replacement

Diskapi Teaching and Research Hospital1 site in 1 country58 target enrollmentOctober 1, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain Measurement
Sponsor
Diskapi Teaching and Research Hospital
Enrollment
58
Locations
1
Primary Endpoint
drain place pain
Status
Completed
Last Updated
5 months ago

Overview

Brief Summary

This prospective clinical study was approved by the institutional ethics committee on September 27, 2023, and patient enrollment started in October 2023. the study aimed to evaluate the contribution of anterior femoral cutaneus nerve block to postoperative analgesia in total knee artroplasty.

The goal of this clinical trial is to compare analhesia effects of adductor canal blockade versus distal adductur canal blockade added anterior cutaneus nerve block in total knee arthroplasty.

The main questions it aims to answer are:

  • question 1: does distal adductor canal blockade + anterior cutaneus nerve blokade superior analgesia then adductor canal block for undergoing TKP?
  • question 2: does distal adductor canal blockade + anterior cutaneus nerve blokade decrease drain place pain on anterolateral face of knee?

Detailed Description

Patients with American Society of Anesthesiologists classification status I-III scheduled for elective primary TKA using standard spinal anesthesia enroll for this trial. After surgery patient divided two groups: 1- adductor canal blockade 2- distal adductor canal blockade + anterior femoral cutaneus nerve blockade. At postoperative 3th, 10th, 24th hour VAS (visuel analouge scale), VAS move, incision plase pain-for top and down of patella, drain place pain, motor strenght for femoral nerve and siyatic nerve, first analjesic requirement time, opioid consumption, total analcesic requirement will be recorded.

Registry
clinicaltrials.gov
Start Date
October 1, 2023
End Date
June 30, 2024
Last Updated
5 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

derya özkan

professor

Diskapi Teaching and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Total knee artroplasty
  • Spinal anesthesia

Exclusion Criteria

  • Bupivacaine allergy
  • Coagulopathy
  • Infection on injection site

Outcomes

Primary Outcomes

drain place pain

Time Frame: postblock 3 hour,10 hour, 24 hour

do you have any pain on drain place? yes or no

VAS (visuel analouge scale)

Time Frame: postblock 3 hour,10 hour, 24 hour

for postoperative pain evaluation after TKA surgery. The visual analogue scale (VAS) uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end.

Secondary Outcomes

  • motor strenght(postblock 3 hour,10 hour, 24 hour)
  • VAS movement(postblock 3 hour,10 hour, 24 hour)

Study Sites (1)

Loading locations...

Similar Trials